Working… Menu

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03646123
Recruitment Status : Recruiting
First Posted : August 24, 2018
Last Update Posted : June 1, 2021
Bristol-Myers Squibb
Information provided by (Responsible Party):
Seagen Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 7, 2022
Estimated Study Completion Date : June 7, 2026